← Evidence map

ArticleOncotarget2017

AHNAK2 is a potential prognostic biomarker in patients with PDAC.

Di Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

29 papers cite it

2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 28423668